Lepu Scientech Medical Technology (Shanghai) Co (HKSE:02291) Cash-to-Debt : 519.11 (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Lepu Scientech Medical Technology (Shanghai) Co Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Lepu Scientech Medical Technology (Shanghai) Co's cash to debt ratio for the quarter that ended in Dec. 2023 was 519.11.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Lepu Scientech Medical Technology (Shanghai) Co could pay off its debt using the cash in hand for the quarter that ended in Dec. 2023.

The historical rank and industry rank for Lepu Scientech Medical Technology (Shanghai) Co's Cash-to-Debt or its related term are showing as below:

HKSE:02291' s Cash-to-Debt Range Over the Past 10 Years
Min: 43.64 Med: 161.43 Max: 519.11
Current: 519.11

During the past 5 years, Lepu Scientech Medical Technology (Shanghai) Co's highest Cash to Debt Ratio was 519.11. The lowest was 43.64. And the median was 161.43.

HKSE:02291's Cash-to-Debt is ranked better than
92.16% of 855 companies
in the Medical Devices & Instruments industry
Industry Median: 1.89 vs HKSE:02291: 519.11

Lepu Scientech Medical Technology (Shanghai) Co Cash-to-Debt Historical Data

The historical data trend for Lepu Scientech Medical Technology (Shanghai) Co's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Lepu Scientech Medical Technology (Shanghai) Co Cash-to-Debt Chart

Lepu Scientech Medical Technology (Shanghai) Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

43.64

161.43

115.32

360.63

519.11

Lepu Scientech Medical Technology (Shanghai) Co Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Cash-to-Debt	Get a 7-Day Free Trial			115.32	116.99	360.63	311.75	519.11

Competitive Comparison of Lepu Scientech Medical Technology (Shanghai) Co's Cash-to-Debt

For the Medical Devices subindustry, Lepu Scientech Medical Technology (Shanghai) Co's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lepu Scientech Medical Technology (Shanghai) Co's Cash-to-Debt Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lepu Scientech Medical Technology (Shanghai) Co's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Lepu Scientech Medical Technology (Shanghai) Co's Cash-to-Debt falls into.

Lepu Scientech Medical Technology (Shanghai) Co Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Lepu Scientech Medical Technology (Shanghai) Co's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	1385.504	/	(1.467	+	1.202)
	=	519.11

Lepu Scientech Medical Technology (Shanghai) Co's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	1385.504	/	(1.467	+	1.202)
	=	519.11

Lepu Scientech Medical Technology (Shanghai) Co (HKSE:02291) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Lepu Scientech Medical Technology (Shanghai) Co Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Lepu Scientech Medical Technology (Shanghai) Co's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Lepu Scientech Medical Technology (Shanghai) Co (HKSE:02291) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lepu Scientech Medical Technology (Shanghai) Co Ltd (HKSE:02291) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 258, Xinzhuan Road, 1st Floor, 5th Floor Building 41, Songjiang District, Shanghai, CHN, 201612

Website

http://www.scientechmed.com

Lepu Scientech Medical Technology (Shanghai) Co Ltd is focused on the research and development, production and marketing of structural heart disease medical interventional devices.

Executives

Pu Zhongjie	2201 Interest of corporation controlled by you
Le Pu Bei Jing Yi Liao Qi Xie Gu Fen You Xian Gong Si	2201 Interest of corporation controlled by you

Lepu Scientech Medical Technology (Shanghai) Co (HKSE:02291) Headlines

No Headlines